Moderna Inc could take months to begin shipping a COVID-19 vaccine that works specifically against the Omicron variant, its chief executive officer, Stéphane Bancel, told CNBC on Monday.
The Omicron variant carries a very high global risk of surges, the WHO warned on Monday, as more countries reported cases.
Bancel told CNBC in an interview that the efficacy of COVID-19 vaccines against the variant was currently not known, and that there should be more clarity in about two weeks.
Moderna said on Friday it was working to advance a booster candidate tailored to the new variant and has also been testing
Disclaimer: No Business Standard Journalist was involved in creation of this content